Aequus Pharmaceuticals Inc Share Price Toronto S.E.
Equities
CA0076361033
Pharmaceuticals
Sales 2022 | 1.38M 1.01M 79M | Sales 2023 | 255K 186K 14.59M | Capitalization | 3.32M 2.42M 190M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.19M -172M | Net income 2023 | -2M -1.46M -115M | EV / Sales 2022 | 5.17 x |
Net Debt 2022 | 2.49M 1.82M 142M | Net Debt 2023 | 4.85M 3.54M 278M | EV / Sales 2023 | 32 x |
P/E ratio 2022 |
-1.45
x | P/E ratio 2023 |
-1.12
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.32% |
Managers | Title | Age | Since |
---|---|---|---|
Anne Stevens
FOU | Founder | - | 31/12/12 |
Douglas Janzen
CEO | Chief Executive Officer | 56 | 02/01/13 |
Ann Fehr
DFI | Director of Finance/CFO | 55 | 21/07/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Janzen
CEO | Chief Executive Officer | 56 | 02/01/13 |
Marc Lustig
BRD | Director/Board Member | 51 | 14/02/21 |
Director/Board Member | 54 | 17/12/14 |
1st Jan change | Capi. | |
---|---|---|
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B |